Oventus is an Australian medical device company with a proprietary
technology for the treatment of obstructive sleep apnea (OSA). Our
focus is on treating those patients that are not being, or cannot be
treated effectively with existing treatment modalities.
OSA is a massive, multibillion dollar and fast growing market
There is a huge unmet need many times the size of the existing market due to the abandonment of existing treatments by the majority of patients.
Oventus has a clinically proven ability to deliver superior outcomes for
more than 80% of these patients with the first products in its treatment
platform currently launching in the US with FDA clearance and existing reimbursement codes.
To view a copy of the presentation please download the attached PDF:
Download this document
